Description: SanBio Company Limited develops, produces, and sells regenerative cell medicines for central nervous system. It develops SB623, a therapeutic product for various stroke patients. The company was founded in 2001 and is headquartered in Tokyo, Japan.
Home Page: www.sanbio.jp
St. Luke Tower
Tokyo,
104-0044
Japan
Phone:
81 3 6264 3481
Officers
| Name | Title |
|---|---|
| Mr. Toru Kawanishi | Co-Founder & Exec. Chairman |
| Mr. Keita Mori MBA | Co-Founder, Pres, Exec. Officer, CEO & Representative Director |
| Mr. Akihiro Tsujimura M.B.A. | Exec. VP, COO & Representative Director |
| Mr. Yoshihiro Kakutani | Corp. Officer of Management Admin. |
| Mr. Greg Gillas | Sr. VP of HR & Corp. Services |
| Dr. Michael P. McGrogan | Sr. VP of Production Devel. |
| Dr. Bijan Nejadnik | Corp. Officer, Chief Medical Officer & Head of Research |
| Mr. Naoki Tsukahara | Corp. Officer & Bus. Head (Japan/Asia) |
| Dr. Kazumi Sawaguchi Ph.D. | Corp. Officer and Head of Japan Regulatory Affairs & Quality Compliance Japan |
| Mr. Andrew Liu | Corp. Officer & Chief Strategy Officer |
Exchange: OTCGREY
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 11.6331 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | January |
| Full Time Employees: | 89 |